Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
afebrile
ANA
anti Hu antibody
anti Ma
anti MAG antibodies
anti Ri antibody
anti Yo antibody
antibodies to myelin basic protein
antimyelin antibodies
aphasia
areflexia
ascending paralysis
ataxia
ataxia, truncal
ataxic gait
athetosis
atypical
autoantibodies
autoimmune disease
basal ganglia, lesion of
basal ganglia, lesion, bilateral
brachial neuritis
brainstem, lesion of
brainstem, surface lesion of, hyperintense
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of ovary
central vein sign
cerebellar lesion
cerebellar peduncle
cerebellum
cerebral cortex
cerebral cortical encephaliis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
children
chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
comorbidities
confusion
confusional state, acute
conus medullaris, lesion of
cranial nerve palsies
deep gray nuclei
demyelinating disease
diagnostic criteria
differential diagnosis
diplopia
disability, neurological
drowsiness
dysarthria
echolalia
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalomyelitis
encephalopathy
encephalopathy, progressive
eye movement, painful
eye, pain in
false positive
familial
fever
FLAMES
gait disorder
GALOP syndromes
gyrus, abnormal
headache
heralding manifestation
hiccoughs
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
H-sign, spinal cord
idiopathic
imbalance
immunologic disease
immunomodulation
immunosuppressive agents
infection
limbic encephalitis
memory, defect of recent
memory, impairment of
meningeal enhancement
middle cerebellar peduncle
middle cerebellar peduncle, lesion
middle cerebellar peduncle, lesion, bilateral
mimics
misdiagnosis
monoclonal gammopathy
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, cloud-like
MRI, cortical enhancement
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, FLAIR
MRI, gyral enhancement
MRI, optic nerve
MRI, serial
MRI, spinal cord
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, clinical patterns
multiple sclerosis, diagnosis of
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, tumefactive
myasthenic syndrome
myelitis
myelitis, longitudinal
myelitis, transverse
myelitis, transverse, idiopathic
myelopathy
myelopathy, ischemic
myopathy
nausea and vomiting
nerve conduction studies
neuroinfectious diseases
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic examination, focal
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuromyelitis optica, IgG
neuropathology
neuropathy
neuropathy, chronic
neuropathy, demyelinating
neuropathy, peripheral, treatment
NMDA antagonists
old age, neurology of
opsoclonus
opsoclonus-myoclonus syndrome
optic disc edema
optic nerve sheath enhancement
optic nerve, enlarged
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, recurrent
optical coherence tomography
overlap syndrome
pain
pain, back
paraparesis, flaccid
paraproteinemia
paresthesias
paresthesias, feet
paresthesias, hands
paroxysmal neurologic disorder
perineuritis
perineuritis, optic
pleocytosis of cerebrospinal fluid
pleocytosis of cerebrospinal fluid, neutrophilic
POEMS syndrome
polyneuropathy
pons, lesion of
posterior leukoencephalopathy syndrome
pregnancy, neurologic complications in
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
Purkinje cell
quadriparesis
recurrent
Red flags
remote effect of cancer on the nervous system
respirator
respiratory failure
review article
rituximab
sarcoidosis, CNS
screening
seizure
seizure, children
seizure, focal
sensory level
serologic testing
serologic testing of cerebrospinal fluid
seronegative
seropositive
spinal cord, compression of
spinal cord, lesion of
strokelike episodes
thalamus, lesion of
thalamus, lesion of-bilateral
thymoma
treatment of neurologic disorder
tumefactive lesion
urinary retention
vision loss, sequential
vision, blurred
visual loss
visual loss, progressive
visual loss, sudden
water channel antibodies
weakness
weakness, generalized
white matter disease
workup
Showing articles 550 to 600 of 1117 << Previous Next >>

Clinicopath Conf, Atypical Carcinoid Tumor with Limbic Encephalitis
NEJM 359:2155-2164, Case 35-2008, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Recurrent Guillain-Barr� Syndrome
JNNP 80:56-59, Kuitwaard,K.,et al, 2008

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Clinicopath Conf., Paraneoplastic Cerebellar Degeneration Due to Anti-Yo Antibodies From Breast Cancer
NEJM 356:612-620, Case 4-2007, 2007

Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated With Ovarian Teratoma
Ann Neurol 61:25-36,3, Dalmau,J.,et al, 2007

Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol 64:178-180, Keane,J.R., 2007

Intravenous Immunoglobulin Therapy for Miller Fisher Syndrome
Neurol 68:1144-1146, Mori,M.,et al, 2007

Autoimmune Limbic Encephalitis in 39 Patients: Immunophenotypes and Outcomes
JNNP 78:381-385,332, Bataller,L.,et al, 2007

Sumatriptan-Naproxen for Acute Treatment of Migraine, A Randomized Trial
JAMA 297:1443-1454, Brandes,J.L.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Limbic Encephalitis as a Precipitating Event in Adult-Onset Temporal Lobe Epilepsy
Neurol 69:1236-1244, Bien,C.G.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Mysterious Falls and a Nasal Voice
Lancet 370:712, Bhandari,A. &Adenwalla,F., 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Assessment of Declofenac or Spinal Manipulative Therapy, Or Both, in Addition to Recommended First-Line Treatment for Acute Low Back Pain: A Randomised Controlled Trial
Lancet 370:1638-1643, Hancock,M.J., et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Antiedema Therapy in Ischemic Stroke
Stroke 38:3084-3094, Bardutzky,J. &Schwab,S., 2007

Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barr� Syndrome
Arch Neurol 64:1519-1523, Nagashima,T.,et al, 2007

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007

Course and Outcome of Acute Limbic Encephalitis With Negative Voltage-Gated Potassium Channel Antibodies
JNNP 78:391-394, Samarasekera,S.R., et al, 2007

Limbic Encephalitis: Under-Recognition of Voltage-Gated Potassium Channel Antibodies
Eur Neurol 58:184, Irani,S.R., et al, 2007

Autoimmune Encephalopathies
The Neurologist 13:140-147, Vernino, S.,et al, 2007

Asymmetric Cerebellar Ataxia and Limbic Encephalitis as a Presenting Feature of Primary Sjogrens Syndrome
J Neurol 254:1609-1611, Collison,K. and Rees,J., 2007

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
Emerg Infect Dis 13:469-471, Meersseman, W.,et al, 2007

Non-Herpetic Acute Limbic Encephalitis-like Manifestation in a Case of Hashimotos Encephalopathy with Positive Autoantibodies against Ionotropic Glutamate Receptor Epsilon
Rinsho Shinkeigaku 47:629-634, Shindo, A.,et al, 2007

ANCA-Associated Vasculitis (AAV) causing Bilateral Cerebral Infarction and Subsequent Intracerebral Hemorrhage without Renal and Respiratory Dysfunction
J Neurol Sci 240:99-101, Ito, Y.,et al, 2006

Voltage-Gated Potassium Channel Antibodies Associated Limbic Encephalitis in a Patient with Invasive Thymoma
J Neurol Sci 250:167-169, Ohshita,T., et al, 2006

Voltage-Gated Potassium Channel Antibody-Associated Encephalitis with Basal Ganglia Lesions
Neurol 66:1780-1781, Hiraga,A., et al, 2006

A Case of Voltage-Gated Potassium Channel Antibody-Related Limbic Encephalitis
Nat Clin Pract Neurol 2:339-343, Harrower,T., et al, 2006

Psychiatric Presentation of Voltage-Gated Potassium Channel Antibody-Associated Encephalopathy
Br J Psychiatry 189:182-183, Parathasarathi,U.D., et al, 2006

Isolated Abducens Nerve Palsy as a Regional Variant of Guillain-Barre Syndrome
JNS 243:35-38, Tatsumoto, M.,et al, 2006

Recent Advances in the Diagnosis and Management of Migraine
BMJ 332:25-29, Goadsby,P.J., 2006

Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006

Paraneoplastic Encephalomyelitis Associated with Pancreatic Tumor and anti-GAD Antibodies
Neurol 66:450-451, Hernandez-Echebarria,L.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Pre- and Posttreatment MR Imaging Findings in Lead Encephalopathy
AJNR 27:902-903, Atre,A.L.,et al, 2006



Showing articles 550 to 600 of 1117 << Previous Next >>